Lobbying client

KING PHARMACEUTICALS

The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.

Filings
6
Filed by
2
Reported in-house
—
Reported by firms
$410,000

Reported lobbying by year

The larger of in-house and firm-reported each year, $ thousands 2007 to 2011

Filings

6 filings, newest first.
Filing Filed by Amount
1st Quarter - Termination (No Activity)
1st Quarter 2011
SQUIRE PATTON BOGGS — reported
4th Quarter - Report
4th Quarter 2010
SQUIRE PATTON BOGGS $210,000 reported
3rd Quarter - Report
3rd Quarter 2010
SQUIRE PATTON BOGGS $140,000 reported
Registration
3rd Quarter 2010
SQUIRE PATTON BOGGS — reported
Year-End Termination
Year-End 2007
D. LYNN JOHNSON $30,000 reported
Mid-Year Report
Mid-Year 2007
D. LYNN JOHNSON $30,000 reported

Filed by

Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.

FirmReportsAmount
SQUIRE PATTON BOGGS 3 $350,000
D. LYNN JOHNSON 2 $60,000

Issues lobbied

How many report sections named each issue, counting the current version of each report.

IssueCodeMentions
Health Issues HCR 3
Pharmacy PHA 2
Aviation/Airlines/Airports AVI 1

From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.